Videos

Open Orphan: Global Leader in Human Challenge Vaccine Development | Executive Chairman Cathal Friel

Open Orphan to become ‘$1bln firm in very near future’ after COVID-19 study receives ethics approval

hVIVO secure MHRA approval to start Codagenix COVID-19 Phase I Vaccine Trial

Shares Investor Evening with Cathal Friel December 2020

Codagenix Covid vaccine phase I study approval interview on Sky News with Cathal Friel

Open Orphan 2020 Year in Review

COVID-19: UK scientists to infect volunteers with coronavirus in world first vaccine trial

Young people to be deliberately exposed to Covid-19 to speed up vaccine development

Market Coverage: Tuesday October 20 Yahoo Finance

Shares Magazine Investor Evening October 2020

Open Orphan Dual Business Firing on All Four Cylinders

Open Orphan Interim Results Interview with BRR Media

Interview with Proactive Investors following £4M contract with Top 3 Global Pharma company

Open Orphan awarded contract from Codagenix for COVID-19 Vaccine Trial

Open Orphan pushes ahead with hVIVO COVID Clear, the ‘most accurate’ antibody test

Coronavirus: I took a COVID-19 antibody test to see if I’d had coronavirus without realising it

Shares Magazine Open Orphan (ORPH) Presentation – Cathal Friel, Executive Chairman

hVIVO – Introduction to our Quarantine & Medical Facilities

BBC – The truth about your medicine cabinet

hVIVO (formerly, and at the time of filming, Retroscreen) on BBC1 The One Show September 2014

FluCamp – what it is like to participate in a clinical trial